163 related articles for article (PubMed ID: 28052033)
1. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer.
Yang J; Wen J; Tian T; Lu Z; Wang Y; Wang Z; Wang X; Yang Y
Oncotarget; 2017 Feb; 8(7):11788-11796. PubMed ID: 28052033
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients.
Sharen G; Peng Y; Cheng H; Liu Y; Shi Y; Zhao J
Oncotarget; 2017 Mar; 8(12):19760-19767. PubMed ID: 28178665
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.
Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H
Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852
[TBL] [Abstract][Full Text] [Related]
4. Potential Role of Glucose Transporter-1 Expression in Gastric Cancer: A Meta-Analysis and Systematic Review.
Tao J; Zhang Y; Wang T
Iran J Public Health; 2020 Nov; 49(11):2044-2053. PubMed ID: 33708725
[TBL] [Abstract][Full Text] [Related]
5. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis.
Liu Y; Tang W; Wang J; Xie L; Li T; He Y; Qin X; Li S
Diagn Pathol; 2013 Nov; 8():181. PubMed ID: 24188373
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
9. High Vimentin Expression Predicts a Poor Prognosis and Progression in Colorectal Cancer: A Study with Meta-Analysis and TCGA Database.
Du L; Li J; Lei L; He H; Chen E; Dong J; Yang J
Biomed Res Int; 2018; 2018():6387810. PubMed ID: 29955607
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis.
Zhou N; Gu Q
Medicine (Baltimore); 2018 Mar; 97(12):e0195. PubMed ID: 29561443
[TBL] [Abstract][Full Text] [Related]
11. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
[TBL] [Abstract][Full Text] [Related]
12. The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.
Ye D; Jiang D; Li Y; Jin M; Chen K
Int J Clin Oncol; 2017 Aug; 22(4):749-757. PubMed ID: 28343299
[TBL] [Abstract][Full Text] [Related]
13. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis.
Wu SW; Ma CC; Li WH
Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145
[TBL] [Abstract][Full Text] [Related]
14. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.
Calik I; Calik M; Turken G; Ozercan IH
Int J Clin Exp Pathol; 2020; 13(2):107-121. PubMed ID: 32211091
[TBL] [Abstract][Full Text] [Related]
15. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis.
Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z
BMC Cancer; 2015 Dec; 15():948. PubMed ID: 26674601
[TBL] [Abstract][Full Text] [Related]
16. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
18. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
19. Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis.
Zhang C; Tan Y; Xu H
Int J Colorectal Dis; 2019 Oct; 34(10):1661-1671. PubMed ID: 31446479
[TBL] [Abstract][Full Text] [Related]
20. The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.
Zhao M; Liang F; Zhang B; Yan W; Zhang J
Sci Rep; 2015 Aug; 5():12713. PubMed ID: 26234583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
